Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Okada

Showing results (371-380 of 742) with videos related to

Pageof 75
Sort By:
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|March 12, 2019
[Metachronous intraductal papillary mucinous carcinoma five years after cholecystectomy for gallbladder cancer in a patient with pancreaticobiliary maljunction]Ailee Ikeda, Kazuyuki Matsumoto, Hironari Kato, et al.
Infection and Drug Resistance|March 19, 2019
Increase in antibiotic resistant <i>Helicobacter pylori</i> in a University Hospital in JapanChihiro Kageyama, Mayu Sato, Hiroyuki Sakae, et al.
Acta Medica Okayama|April 27, 2011
Usefulness and problems of endoscopic ultrasonography in prediction of the depth of tumor invasion in early gastric cancerTakao Tsuzuki, Hiroyuki Okada, Yoshiro Kawahara, et al.
BMC Gastroenterology|May 1, 2015
The earliest trough concentration predicts the dose of tacrolimus required for remission induction therapy in ulcerative colitis patientsSakiko Hiraoka, Jun Kato, Yuki Moritou, et al.
Journal of Medical Microbiology|February 19, 2004
Characterization of elongated Helicobacter pylori isolated from a patient with gastric-mucosa-associated lymphoid-tissue lymphomaTatsuya Toyokawa, Kenji Yokota, Motowo Mizuno, et al.
The Journal of Laboratory and Clinical Medicine|April 16, 2004
Enhanced expression of decay-accelerating factor, a complement-regulatory protein, in the specialized intestinal metaplasia of Barrett's esophagusSakiko Hiraoka, Motowo Mizuno, Junichirou Nasu, et al.
The Journal of Laboratory and Clinical Medicine|March 10, 2004
Difference in Ulex europaeus agglutinin I-binding activity of decay-accelerating factor detected in the stools of patients with colorectal cancer and ulcerative colitisHiroaki Okazaki, Motowo Mizuno, Junichirou Nasu, et al.
Journal of Gastroenterology and Hepatology|December 22, 2004
Stool decay-accelerating factor as a marker for monitoring the disease activity during leukocyte apheresis therapy in patients with refractory ulcerative colitisHiroyuki Kohno, Motowo Mizuno, Junichirou Nasu, et al.
World Journal of Gastroenterology|November 28, 2012
Clinicopathological characteristics of human epidermal growth factor receptor 2-positive Barrett's adenocarcinomaTakehiro Tanaka, Atsushi Fujimura, Koichi Ichimura, et al.
Internal Medicine (Tokyo, Japan)|February 6, 2020
Clinical Characteristics and Risk Factors for Rebleeding in Patients with Obscure Gastrointestinal BleedingYuki Baba, Seiji Kawano, Yoshiyasu Kono, et al.
Pageof 75

Showing results (371-380 of 742) with videos related to

Sort By:
Pageof 75
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|March 12, 2019
[Metachronous intraductal papillary mucinous carcinoma five years after cholecystectomy for gallbladder cancer in a patient with pancreaticobiliary maljunction]Ailee Ikeda, Kazuyuki Matsumoto, Hironari Kato, et al.
Infection and Drug Resistance|March 19, 2019
Increase in antibiotic resistant <i>Helicobacter pylori</i> in a University Hospital in JapanChihiro Kageyama, Mayu Sato, Hiroyuki Sakae, et al.
Acta Medica Okayama|April 27, 2011
Usefulness and problems of endoscopic ultrasonography in prediction of the depth of tumor invasion in early gastric cancerTakao Tsuzuki, Hiroyuki Okada, Yoshiro Kawahara, et al.
BMC Gastroenterology|May 1, 2015
The earliest trough concentration predicts the dose of tacrolimus required for remission induction therapy in ulcerative colitis patientsSakiko Hiraoka, Jun Kato, Yuki Moritou, et al.
Journal of Medical Microbiology|February 19, 2004
Characterization of elongated Helicobacter pylori isolated from a patient with gastric-mucosa-associated lymphoid-tissue lymphomaTatsuya Toyokawa, Kenji Yokota, Motowo Mizuno, et al.
The Journal of Laboratory and Clinical Medicine|April 16, 2004
Enhanced expression of decay-accelerating factor, a complement-regulatory protein, in the specialized intestinal metaplasia of Barrett's esophagusSakiko Hiraoka, Motowo Mizuno, Junichirou Nasu, et al.
The Journal of Laboratory and Clinical Medicine|March 10, 2004
Difference in Ulex europaeus agglutinin I-binding activity of decay-accelerating factor detected in the stools of patients with colorectal cancer and ulcerative colitisHiroaki Okazaki, Motowo Mizuno, Junichirou Nasu, et al.
Journal of Gastroenterology and Hepatology|December 22, 2004
Stool decay-accelerating factor as a marker for monitoring the disease activity during leukocyte apheresis therapy in patients with refractory ulcerative colitisHiroyuki Kohno, Motowo Mizuno, Junichirou Nasu, et al.
World Journal of Gastroenterology|November 28, 2012
Clinicopathological characteristics of human epidermal growth factor receptor 2-positive Barrett's adenocarcinomaTakehiro Tanaka, Atsushi Fujimura, Koichi Ichimura, et al.
Internal Medicine (Tokyo, Japan)|February 6, 2020
Clinical Characteristics and Risk Factors for Rebleeding in Patients with Obscure Gastrointestinal BleedingYuki Baba, Seiji Kawano, Yoshiyasu Kono, et al.
Pageof 75